Brain Injuries, Acute Clinical Trial
Official title:
Study on Additive Use of Non-invasive Acustocerebrography in Patients Suspect to Severe Brain Injury
The study will enable the clinical applicability of the multiple-spectral-sonography for detection of severe brain injury in ICU patients. For this, the ACG diagnostic system (Sonovum AG, Leipzig, Germany) should be used as additional diagnostic tool in prospective single-center study.
A multiple-step procedure, including repetition of the clinical examinations after a waiting
period and use of additional technical diagnostic tools e.g. magnetic resonance tomography
and Transcranial Doppler sonography (TCD) are needed for determining of severe brain injury
and irreversible brain function failure.
This study will enable the clinical applicability of the multiple-spectral-sonography for
detection of severe brain injury in ICU patients. For this, the ACG diagnostic system
(Sonovum AG, Leipzig, Germany) should be used as additional diagnostic tool in prospective
single-center study.
The ACG-method is a bedside non-invasive sonography that has been shown to be useful in
previous studies analyzing circulatory changes in rat cerebral blood vessels, for example, to
distinguish between brain-ischemia and -hemorrhage. Additionally, in the case of brain death,
the spontaneous electrical activity, which can be measured by means of ACG as global
elasticity, was not longer detectable.
In the study should include 30 adult ICU-patients in patients suspect to severe brain injury.
The inclusion of patients will be started if written informed consent was obtained from
participants or their representatives. After the inclusion, the ACG is measured three times a
day. In addition, the routinely practice (treatment and diagnostic) for patients with severe
brain injury (neurological clinical examinations, use of additional technical diagnostic
tools e.g. magnetic resonance tomography and Transcranial Doppler sonography (TCD); Standard
Medical Care) should be made and documented. From all patients basic demographic data,
pre-morbidity, vital parameters, blood parameters, Illness severity scores (APACHE-II, SOFA,
GCS), drug levels, microbiological results and cranial MRI/CT results will be recorded.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02525432 -
Autologous Stem Cell Study for Adult TBI (Phase 2b)
|
Phase 2 | |
Recruiting |
NCT06081283 -
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
|
Phase 4 | |
Recruiting |
NCT06370520 -
Screening Emotions in Adolescents at the Hospital for mTBI
|
||
Recruiting |
NCT04905264 -
Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care
|
||
Completed |
NCT03362346 -
Signal Analysis for Neurocritical Patients
|
||
Recruiting |
NCT06367816 -
Brain Recovery With Automated VEntilation
|